Jim P Buttery

Summary

Affiliation: Royal Children's Hospital
Country: Australia

Publications

  1. ncbi request reprint Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial
    Jim P Buttery
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford, UK
    JAMA 293:1751-8. 2005
  2. doi request reprint Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia
    J P Buttery
    SAEFVIC in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Parkville, Victoria 3052, Australia
    Vaccine 29:3061-6. 2011
  3. ncbi request reprint Mass psychogenic response to human papillomavirus vaccination
    Jim P Buttery
    SAEFVIC, Murdoch Childrens Research Institute, Royal Children s Hospital, and Department of Paediatrics, University of Melbourne, Melbourne, Vic, Australia
    Med J Aust 189:261-2. 2008
  4. ncbi request reprint A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge ph
    Anna Riddell
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, UK
    Vaccine 25:3906-12. 2007
  5. ncbi request reprint Changes in the epidemiology of gastroenteritis in a paediatric short stay unit following the introduction of rotavirus immunisation
    Jonathan D Akikusa
    Department of General Medicine, Royal Children s Hospital, Melbourne, Victoria, Australia
    J Paediatr Child Health 49:120-4. 2013
  6. doi request reprint Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination
    Celeste M Donato
    Enteric Virus Group, Murdoch Childrens Research Institute, Royal Children s Hospital, Melbourne, Australia
    J Infect Dis 206:377-83. 2012
  7. doi request reprint Recurrent apnoea post immunisation: Informing re-immunisation policy
    Vanessa Clifford
    SAEFVIC, Murdoch Children s Research Institute, Melbourne, Australia
    Vaccine 29:5681-7. 2011
  8. doi request reprint Survivors of childhood cancer: an Australian audit of vaccination status after treatment
    Nigel W Crawford
    NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunization, Parkville, Vic, Australia
    Pediatr Blood Cancer 54:128-33. 2010
  9. pmc An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease
    Nigel W Crawford
    SAEFVIC, Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria 3011, Australia
    BMC Gastroenterol 11:87. 2011
  10. ncbi request reprint Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria
    Hazel J Clothier
    SAEFVIC, Murdoch Childrens Research Institute, Parkville, Victoria
    Commun Dis Intell Q Rep 35:294-8. 2011

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial
    Jim P Buttery
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford, UK
    JAMA 293:1751-8. 2005
    ....
  2. doi request reprint Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia
    J P Buttery
    SAEFVIC in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Parkville, Victoria 3052, Australia
    Vaccine 29:3061-6. 2011
    ..In Australia, post-marketing surveillance for intussusception following vaccination commenced with funding of RotaTeq(®) and Rotarix(®) vaccines under the National Immunization Program (NIP) in July 2007...
  3. ncbi request reprint Mass psychogenic response to human papillomavirus vaccination
    Jim P Buttery
    SAEFVIC, Murdoch Childrens Research Institute, Royal Children s Hospital, and Department of Paediatrics, University of Melbourne, Melbourne, Vic, Australia
    Med J Aust 189:261-2. 2008
  4. ncbi request reprint A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge ph
    Anna Riddell
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, UK
    Vaccine 25:3906-12. 2007
    ..This study describes the persistence of immunity at 12 months of age and the immunologic response to a challenge dose of either meningococcal polysaccharide vaccine (Meningivac A+C; MnA+C), or MenC...
  5. ncbi request reprint Changes in the epidemiology of gastroenteritis in a paediatric short stay unit following the introduction of rotavirus immunisation
    Jonathan D Akikusa
    Department of General Medicine, Royal Children s Hospital, Melbourne, Victoria, Australia
    J Paediatr Child Health 49:120-4. 2013
    ..This study aimed to examine changes in the epidemiology of AGE in the SSU, and RCH overall, between 2005 and 2009 and explore whether this reflects a change specifically in AGE due to rotavirus...
  6. doi request reprint Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination
    Celeste M Donato
    Enteric Virus Group, Murdoch Childrens Research Institute, Royal Children s Hospital, Melbourne, Australia
    J Infect Dis 206:377-83. 2012
    ..This study identified and characterised rotavirus strains excreted by infants who presented with symptoms of gastroenteritis following recent RotaTeq vaccination...
  7. doi request reprint Recurrent apnoea post immunisation: Informing re-immunisation policy
    Vanessa Clifford
    SAEFVIC, Murdoch Children s Research Institute, Melbourne, Australia
    Vaccine 29:5681-7. 2011
    ..The risk factors for, and recurrence rate of apnoea with subsequent immunisations are unknown, which makes planning for subsequent immunisations for these highly vulnerable infants difficult...
  8. doi request reprint Survivors of childhood cancer: an Australian audit of vaccination status after treatment
    Nigel W Crawford
    NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunization, Parkville, Vic, Australia
    Pediatr Blood Cancer 54:128-33. 2010
    ..The aim of this study was to describe the compliance of post-chemotherapy revaccination of childhood cancer survivors relative to current Australian guidelines...
  9. pmc An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease
    Nigel W Crawford
    SAEFVIC, Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria 3011, Australia
    BMC Gastroenterol 11:87. 2011
    ..The primary aim of this study was to describe compliance with current Australian guidelines for vaccination of children and adolescents diagnosed with IBD. A secondary aim was to review the serological screening for VPD...
  10. ncbi request reprint Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria
    Hazel J Clothier
    SAEFVIC, Murdoch Childrens Research Institute, Parkville, Victoria
    Commun Dis Intell Q Rep 35:294-8. 2011
    ..6 per 100,000 in 2003 to 13.5 per 100,000 per annum in 2009. This report describes the SAEFVIC service model and summarises outcomes and lessons learnt in the first 3 years of operation...
  11. doi request reprint Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule
    Jim P Buttery
    Department of General Medicine and Murdoch Children s Research Institute, Royal Children s Hospital Melbourne, Parkville, Victoria, Australia Paediatric Infectious Diseases Unit, Monash Children s Hospital, Department of Paediatrics, Monash University, Melbourne, Victoria
    Pediatr Infect Dis J 30:S25-9. 2011
    ..This allowed comparison of both vaccines in similar populations with high infant vaccination coverage...
  12. ncbi request reprint Immunisation practices of paediatric oncologists: an Australasian survey
    Nigel W Crawford
    NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation Murdoch Children s Research Institute, Royal Children s Hospital, Melbourne, Victoria, Australia
    J Paediatr Child Health 43:593-6. 2007
    ..The aim of this survey was to identify the current practices of paediatric oncologists in Australia and New Zealand regarding the immunisation of children treated for cancer...
  13. ncbi request reprint Combination conjugate vaccines
    Naor Bar-Zeev
    Department of General Medicine, Royal Children s Hospital, Melbourne, Australia
    Expert Opin Drug Saf 5:351-60. 2006
    ..The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed...
  14. ncbi request reprint Syncope and seizures following human papillomavirus vaccination: a retrospective case series
    Nigel W Crawford
    Murdoch Childrens Research Institute, Melbourne, Vic, Australia
    Med J Aust 194:16-8. 2011
    ..To quantify and characterise the reports of syncope and seizures following quadrivalent (4v) human papillomavirus (HPV) vaccination...
  15. ncbi request reprint Immunisation practices in infants born prematurely: neonatologists' survey and clinical audit
    Nigel W Crawford
    National Health and Medical Research Council NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Department of General Medicine, Royal Children s Hospital RCH, Parkville, Victoria, Australia
    J Paediatr Child Health 45:602-9. 2009
    ..To determine Australian neonatologists' recommendations for the immunisation of ex-preterm infants and compare their actual immunisation status with recommended Australian guidelines...
  16. doi request reprint Mumps vaccine associated orchitis: Evidence supporting a potential immune-mediated mechanism
    Vanessa Clifford
    Infectious Diseases Unit, Department of General Medicine and Murdoch Childrens Research Institute, Royal Children s Hospital Melbourne, Parkville, Victoria 3052, Australia
    Vaccine 28:2671-3. 2010
    ..These cases, discussed together with a comprehensive review of the existing literature regarding post-vaccine orchitis, highlight uncertainty regarding the pathogenesis of post-vaccine orchitis...
  17. ncbi request reprint Improving preterm infants' immunisation status: a follow-up audit
    Nigel W Crawford
    SAEFVIC, Murdoch Children s Research Institute MCRI, Melbourne, Victoria, Australia Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria, Australia Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia
    J Paediatr Child Health 50:314-8. 2014
    ..An audit in 2007 identified suboptimal immunisation status of preterm infants. The aim of this study was to complete the 'audit loop', reviewing preterm infants' immunisation status at a single tertiary paediatric hospital...
  18. ncbi request reprint Genetic characterization of a novel G3P[14] rotavirus strain causing gastroenteritis in 12 year old Australian child
    Celeste M Donato
    Enteric Virus Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia Department of Microbiology, La Trobe University, Melbourne, Victoria, Australia Electronic address
    Infect Genet Evol 25:97-109. 2014
    ..However, without screening numerous animal populations it is not possible to determine the origins of this strain. ..
  19. ncbi request reprint Human papillomavirus vaccine in boys: background rates of potential adverse events
    Hazel J Clothier
    Surveillance of Adverse Events Following Vaccination in the Community SAEFVIC, Murdoch Childrens Research Institute, Melbourne, Vic
    Med J Aust 198:554-8. 2013
    ..To determine background rates of potential adverse events following immunisation (AEFI) before expansion of the quadrivalent human papillomavirus (4vHPV) vaccination program to adolescent boys...
  20. ncbi request reprint Rotavirus vaccines in developed countries
    Jim P Buttery
    NHMRC Centre of Clinical Research Excellence in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Infectious Diseases Unit, Royal Children s Hospital, Parkville, Australia
    Curr Opin Infect Dis 20:253-8. 2007
    ..The recent licensure in many nations of vaccines against rotavirus offers promise to significantly reduce this toll. The present review describes recent developments regarding rotavirus vaccines and the challenges they face...
  21. doi request reprint Optimizing immunization in pediatric special risk groups
    Nigel W Crawford
    SAEFVIC, Murdoch Childrens Research Institute, Melbourne, Australia
    Expert Rev Vaccines 10:175-86. 2011
    ..g., varicella, influenza and pertussis vaccination). Improving timeliness and minimizing missed opportunities to vaccinate individuals with these special risk conditions will also optimize protection from vaccine-preventable diseases...
  22. pmc Recurrent 6th nerve palsy in a child following different live attenuated vaccines: case report
    Daryl R Cheng
    Central Medical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
    BMC Infect Dis 12:105. 2012
    ..It has also been temporally associated with immunization, but has not been previously described following two different live attenuated vaccines...
  23. doi request reprint Complex regional pain syndrome following immunisation
    Stephanie Richards
    SAEFVIC, Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria, Australia
    Arch Dis Child 97:913-5. 2012
    ..Enhanced awareness of this syndrome and its potential to occur following immunisation in the paediatric population is vital to the prompt and effective management of this condition...
  24. doi request reprint Active surveillance for adverse events following immunization
    Nigel W Crawford
    SAEFVIC, Murdoch Children s Research Institute MCRI, Parkville, Melbourne, Victoria 3052, Australia
    Expert Rev Vaccines 13:265-76. 2014
    ..Global collaboration is increasingly required to address challenges in active AEFI surveillance, particularly for rare serious adverse events. ..
  25. doi request reprint Minimising missed opportunities to vaccinate
    Nigel W Crawford
    J Paediatr Child Health 44:315-6. 2008
  26. ncbi request reprint Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants
    Clare L Collins
    St George s Hospital Medical School, London, United Kingdom
    Pediatr Infect Dis J 24:966-8. 2005
    ..K. routine immunization schedule in 1999. This study is the first to describe both persistence of antibody and evidence for induction of immune memory using meningococcal C conjugate (MCC) vaccine in preterm infants...